
3478. effect dehydroepiandrosterone 
17-hydroxycorti- 
costeroids plasma various stages 
cancer diseases 
breast 
reducing effect dehydroepiandrosterone 
plasma corticosteroids 
average shortened advanced 
(stage iv) cases breast cancer.  3 
groups patients, lowest corticosteroid 
levels found 6 hr. 
infusion dehydroepiandrosterone-phosphate. 
patients mastopathy 
effect still detectable 12 hr. later; patients 
breast cancer stage iv 
initial levels reached time.  
cases stages ii lesions, 
findings intermediate.  shortening 
attributed intensive 
transformation dehydroepiandrosterone 
advanced cases breast cancer. 
